NORTHANN CORP (NCL)

US66373M2008 - Common Stock

0.26  0 (-0.76%)

Premarket: 0.27 +0.01 (+3.85%)

Fundamental Rating

1

Taking everything into account, NCL scores 1 out of 10 in our fundamental rating. NCL was compared to 39 industry peers in the Building Products industry. Both the profitability and financial health of NCL have multiple concerns. NCL is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

NCL had negative earnings in the past year.
In the past year NCL has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of NCL (-57.52%) is worse than 97.44% of its industry peers.
Looking at the Return On Equity, with a value of -780.02%, NCL is doing worse than 94.87% of the companies in the same industry.
Industry RankSector Rank
ROA -57.52%
ROE -780.02%
ROIC N/A
ROA(3y)-14.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NCL has a Gross Margin of 9.92%. This is amonst the worse of the industry: NCL underperforms 87.18% of its industry peers.
NCL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NCL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.86%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

NCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NCL has less shares outstanding
Compared to 1 year ago, NCL has an improved debt to assets ratio.

2.2 Solvency

NCL has an Altman-Z score of -1.13. This is a bad value and indicates that NCL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.13, NCL is not doing good in the industry: 97.44% of the companies in the same industry are doing better.
NCL has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.12, NCL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -1.13
ROIC/WACCN/A
WACC9.44%

2.3 Liquidity

A Current Ratio of 0.53 indicates that NCL may have some problems paying its short term obligations.
NCL has a worse Current ratio (0.53) than 94.87% of its industry peers.
A Quick Ratio of 0.28 indicates that NCL may have some problems paying its short term obligations.
NCL has a worse Quick ratio (0.28) than 94.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.28

1

3. Growth

3.1 Past

NCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -970.86%.
The Revenue for NCL has decreased by -33.33% in the past year. This is quite bad
NCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.19% yearly.
EPS 1Y (TTM)-970.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.62%
Revenue 1Y (TTM)-33.33%
Revenue growth 3Y2.19%
Revenue growth 5YN/A
Sales Q2Q%-14.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NCL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORTHANN CORP

NYSEARCA:NCL (12/20/2024, 8:26:38 PM)

Premarket: 0.27 +0.01 (+3.85%)

0.26

0 (-0.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change97.01%
Ins Owners59.53%
Ins Owner Change0%
Market Cap8.93M
AnalystsN/A
Price TargetN/A
Short Float %0.48%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B 9.22
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.44
BVpS0.03
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.52%
ROE -780.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.92%
FCFM N/A
ROA(3y)-14.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.86%
GM growth 5YN/A
F-Score1
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.28
Altman-Z -1.13
F-Score1
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-970.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.33%
Revenue growth 3Y2.19%
Revenue growth 5YN/A
Sales Q2Q%-14.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-329.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.39%
OCF growth 3YN/A
OCF growth 5YN/A